Expression of apoptosis regulatory factors during myocardial dysfunction in endotoxemic rats

Critical Care Medicine

Volumn 33, Issue 3, 2005, Pages 492-496

  Lancel, Steve ^a   Petillot, Patrice ^a   Favory, Raphael ^a   Stebach, Nicolas ^b   Lahorte, Christophe ^c   Danze, Pierre Marie ^b   Vallet, Benoît ^a   Marchetti, Philippe ^b   Neviere, Remi ^a  

^a UNIV LILLE   (France)

^b INSERM   (France)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Apoptosis; Bcl 2; Cardiomyopathy; Caspase; Endotoxin

Indexed keywords

CASPASE 3; ENDOTOXIN; LIPOCORTIN 5; PARTHENOLIDE; PHOSPHATIDYLSERINE; PROTEIN BCL 2; SODIUM CHLORIDE;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HEART FUNCTION TEST; HEART MUSCLE INJURY; IMMUNOHISTOCHEMISTRY; ISOLATED HEART; ISOTOPE LABELING; MALE; MORTALITY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; SEPSIS; SURVIVAL RATE; WESTERN BLOTTING; WILD TYPE;

EID: 14944354292     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000156240.31913.4A     Document Type: Article

References (26)

1. Davies MJ: Apoptosis in cardiovascular disease. Heart 1997; 77:498-501
2. Schwartz SM, Duffy JY, Pearl JM, et al: Cellular and molecular aspects of myocardial dysfunction. Crit Care Med 2001; 29:S214-S219
3. McGowan BS, Ciccimaro EF, Chan TO, et al: The balance between pro-apoptotic and antiapoptotic pathways in the failing myocardium. Cardiovasc Toxicol 2003; 3:191-206
4. Green DR, Reed JC: Mitochondria and apoptosis. Science 1998; 281:1309-1312
5. Narula J, Pandey P, Arbustini E, et al: Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A 1999; 96:8144-8149
6. Kumar A, Haery C, Parrillo JE: Myocardial dysfunction in septic shock. Crit Care Clin 2000; 16:251-287
7. McDonald TE, Grinman MN, Carthy CM, et al: Endotoxin infusion in rats induces apoptotic and survival pathways in hearts. Am J Physiol Heart Circ Physiol 2000; 279: H2053-H2061
8. Neviere R, Fauvel H, Chopin C, et al: Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med 2001; 163:218-225
9. Fauvel H, Marchetti P, Chopin C, et al: Differential effects of caspase inhibitors on endotoxin-induced myocardial dysfunction and heart apoptosis. Am J Physiol Heart Circ Physiol 2001; 280:H1608-H1614
10. Hotchkiss RS, Tinsley KW, Swanson PE, et al: Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A 1999; 96:14541-14546
11. Iwata A, Stevenson VM, Minard A, et al: Over-expression of Bcl-2 provides protection in septic mice by a trans effect. J Immunol 2003; 171:3136-3141
12. Coopersmith CM, Chang KC, Swanson PE, et al: Overexpression of Bcl-2 in the intestinal epithelium improves survival in septic mice. Crit Care Med 2002; 30:195-201
13. Lahorte CM, van de Wiele C, Bacher K, et al: Biodistribution and dosimetry study of 1231-rh-annexin V in mice and humans. Nucl Med Commun 2003; 24:871-880
14. Hotchkiss RS, Swanson PE, Freeman BD, et al: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27:1230-1251
15. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150
16. Hotchkiss RS, Chang KC, Swanson PE, et al: Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 2000; 1:496-501
17. Rucker-Martin C, Henaff M, Hatem SN, et al: Early redistribution of plasma membrane phosphatidylserine during apoptosis of adult rat ventricular myocytes in vitro. Basic Res Cardiol 1999; 94:171-179
18. Maulik N, Kagan VE, Tyurin VA, et al: Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. Am J Physiol 1998; 274: H242-H248
19. Blankenberg FC, Katsikis PD, Tait JF, et al: In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998; 95:6349-6354
20. Dumont EA, Hofstra L, van Heerde WL, et al: Cardiomyocyte death induced by myocardial ischemia and reperfusion: Measurement with recombinant human annexin-V in a mouse model. Circulation 2000; 102:1564-1568
21. Narayan P, Mentzer RM Jr, Lasley RD: Annexin V staining during reperfusion detects cardiomyocytes with unique properties. Am J Physiol Heart Circ Physiol 2001; 281:H1931-H1937
22. Laugwitz KL, Moretti A, Weig HJ, et al: Blocking caspase-activated apoptosis improves contractility in failing myocardium. Hum Gene Ther 2001; 12:2051-2063
23. Communal C, Sumandea M, de Tombe P, et al: Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U S A 2002; 99:6252-6256
24. Condorelli G, Roncarati R, Ross J Jr, et al: Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function. Proc Natl Acad Sci U S A 2001; 98:9977-9982
25. Methot N, Huang J, Coulombe N, et al: Differential efficacy of caspase inhibitors on apoptosis markers during sepsis in rats and implication for fractional inhibition requirements for therapeutics. J Exp Med 2004; 199:199-207
26. West MA, Heagy W: Endotoxin tolerance: A review. Crit Care Med 2002; 30:S64-S73